Home › Funds › Trails Edge Capital Partners, LP › IMA

Trails Edge Capital Partners, LP position in IMA

IMAGENEBIO INC · Health Care

Trails Edge Capital Partners, LP reported holding 1,094,045 shares of IMA (IMAGENEBIO INC) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.72% of its reported portfolio and ranking #34 among its reported holdings. Trails Edge Capital Partners, LP has disclosed IMA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.09M sh
Reported value held$5.01M
Portfolio Weight0.72%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's IMA position evolved

Trails Edge Capital Partners, LP first disclosed a stake in IMA in Q2 2026 at 282,004 shares (US$1.7M). The position peaked in Q3 2026 at 1,094,045 shares, worth US$5.0M. Across 2 filings, Trails Edge Capital Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,094,045 shares valued at US$5.0M — an increase of 812,041 shares quarter over quarter.. Notable position changes include a 288% increase in Q3 2026 (shares fell 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 282.00K $1.66M New
Q3 2026 1.09M $5.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMA and 13F data

IMA (IMAGENEBIO INC) is a Health Care company. 38 other funds we track also report a position in IMA — the largest reported positions include BVF INC/IL (US$6.5M), Blue Owl Capital Holdings LP (US$5.2M), Cable Car Capital, LP (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMA

All IMA fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held IMA?

Trails Edge Capital Partners, LP has disclosed IMA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Trails Edge Capital Partners, LP's current position in IMA?

As of Q3 2026, Trails Edge Capital Partners, LP holds 1.09M shares of IMA (IMAGENEBIO INC), valued at $5.01M, representing 0.72% of its reported portfolio and ranking #34.

Has Trails Edge Capital Partners, LP been buying or selling IMA?

In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP increased its position in IMA. The position peaked in Q3 2026 at 1.09M shares.

Which other funds hold IMA?

Other major institutional holders of IMA include BVF INC/IL, Blue Owl Capital Holdings LP, Cable Car Capital, LP, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.